Ellen Jamison Kullman - 19 May 2023 Form 4 Insider Report for AMGEN INC (AMGN)

Role
Director
Signature
/s/ Andrea A. Robinson, Attorney-in-Fact for Ms. Kullman
Issuer symbol
AMGN
Transactions as of
19 May 2023
Transactions value $
$0
Form type
4
Filing time
23 May 2023, 19:26:19 UTC
Previous filing
20 Jan 2023
Next filing
02 Oct 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMGN Common Stock Award $0 +939 +9.14% $0 11,208 19 May 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended (the Director Program), under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vest immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the deferral schedule.
F2 These shares include 987 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.